Stay updated with breaking news from Opgen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report issued on Friday. The brokerage issued a hold rating on the medical research company’s stock. Separately, HC Wainwright downgraded shares of OpGen from a buy rating to a neutral rating in a research note on Monday, August 14th. Get Our Latest […]
StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report issued on Friday morning. The brokerage issued a hold rating on the medical research company’s stock. Separately, HC Wainwright cut OpGen from a buy rating to a neutral rating in a research note on Monday, August 14th. View Our Latest Stock […]
StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research note released on Thursday morning. The brokerage issued a hold rating on the medical research company’s stock. Separately, HC Wainwright downgraded OpGen from a buy rating to a neutral rating in a report on Monday, August 14th. View Our Latest Analysis […]
StockNews.com started coverage on shares of Precigen (NASDAQ:PGEN – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. A number of other equities analysts also recently commented on the stock. JPMorgan Chase & Co. assumed coverage on shares of Precigen in […]
OpGen, Inc. (NASDAQ:OPGN – Get Free Report) was the recipient of a significant growth in short interest in August. As of August 15th, there was short interest totalling 168,000 shares, a growth of 123.1% from the July 31st total of 75,300 shares. Based on an average daily volume of 307,700 shares, the days-to-cover ratio is […]